Cook launches new sizes of peripheral DES
This article was originally published in Clinica
Cook Medical has launched new sizes of its Zilver PTX drug-eluting peripheral stent, designed to treat peripheral artery disease in the superficial femoral artery, in Europe. The paclitaxel-coated device will now be available in lengths up to 120mm and with a 6 French diameter delivery system. Recently clinical data showed that the device causes a 50% reduction in restenosis compared with bare-metal stenting and allows 74.8% primary patency at two years (www.clinica.co.uk, 18 January 2011). Andy Förster, EMEA manager for Cook's peripheral intervention business unit, said: "Since the announcement of this data, adoption of the Zilver PTX has greatly increased." Zilver PTX is not yet approved in the US.